Sensei Biotherapeutics, Inc. (SNSE) Misses Q1 EPS by 4c
Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) reported Q1 EPS of ($0.27), $0.04 worse than the analyst estimate of ($0.23).
For earnings history and earnings-related data on Sensei Biotherapeutics, Inc. (SNSE) click here.
